Literature DB >> 2125610

Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis.

P G Chiodini1, R Attanasio, A Liuzzi, R Cozzi, P Orlandi, C De Palo, D Dallabonzana, F Girotti, D Testa.   

Abstract

In six patients suffering from amyotrophic lateral sclerosis we evaluated changes of T4, T3, TSH, PRL, and GH during treatment by continuous iv infusion of TRH for at least 15 days. No clinical improvement was detected. A significant rise of thyroid hormone levels was observed, as well as an upward trend of basal TSH levels and no change of basal PRL and GH levels. TRH acute test-induced TSH and PRL responses became blunted. Treatment provoked also the onset of a responsiveness of PRL to GHRH. The reduced TSH and PRL responses to acute TRH test during treatment could be explained by a down-regulation of TRH pituitary receptors. On the contrary, the onset of PRL responsiveness to GHRH is at present without a satisfactory explanation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125610     DOI: 10.1007/BF03349584

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Sex difference in human growth hormone (GH) response to intravenous human pancreatic GH-releasing hormone administration in young adults.

Authors:  A E Smals; G F Pieters; A G Smals; T J Benraad; J Van Laarhoven; P W Kloppenborg
Journal:  J Clin Endocrinol Metab       Date:  1986-02       Impact factor: 5.958

2.  Thyrotropin-releasing hormone increases the number of muscarinic receptors in the lateral septal area of the rat brain.

Authors:  C J Pirola; M S Balda; S Finkielman; V E Nahmod
Journal:  Brain Res       Date:  1983-08-29       Impact factor: 3.252

Review 3.  The influence of hyperthyroidism and hypothyroidism on alpha- and beta-adrenergic receptor systems and adrenergic responsiveness.

Authors:  J P Bilezikian; J N Loeb
Journal:  Endocr Rev       Date:  1983       Impact factor: 19.871

4.  Thyrotropin-releasing hormone enhances choline acetyltransferase and creatine kinase in cultured spinal ventral horn neurons.

Authors:  K M Schmidt-Achert; V Askanas; W K Engel
Journal:  J Neurochem       Date:  1984-08       Impact factor: 5.372

5.  The effect of thyroid status on the growth hormone response to growth hormone releasing hormone 1-44.

Authors:  R R Davies; S Dagogo-Jack; S J Turner; P Kendall-Taylor; P Baylis; E Young; M Watson; D G Johnston
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

6.  Effects of human pancreatic tumor growth hormone-releasing hormone (hpGRH1-44-NH2) on immunoreactive and bioactive plasma growth hormone in normal young men.

Authors:  G Sassolas; P Chatelain; R Cohen; J P Boissel; S Laporte; J Galleyrand; B Claustrat; A Elmcharfi; J A Chayvialle; H Cohen
Journal:  J Clin Endocrinol Metab       Date:  1984-10       Impact factor: 5.958

7.  Alterations in receptors for thyrotropin-releasing hormone, serotonin, and acetylcholine in amyotrophic lateral sclerosis.

Authors:  S Manaker; S B Caine; A Winokur
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

8.  Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone.

Authors:  W K Engel; T Siddique; J T Nicoloff
Journal:  Lancet       Date:  1983-07-09       Impact factor: 79.321

9.  Effect of growth hormone-releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children.

Authors:  G Van Vliet; D Bosson; C Robyn; M Craen; P Malvaux; M Vanderschueren-Lodeweyckx; R Wolter
Journal:  Horm Res       Date:  1985

10.  Dose-response relationships for the effects of growth hormone-releasing factor-(1-44)-NH2 in young adult men and women.

Authors:  M C Gelato; O H Pescovitz; F Cassorla; D L Loriaux; G R Merriam
Journal:  J Clin Endocrinol Metab       Date:  1984-08       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.